Business
Zealand Pharma Faces Share Drop Over Drug Trial Issues
Zealand Pharma’s shares fell by a fifth after many users discontinued its weight-loss drug due to gastrointestinal issues during the trial. The company announced this in Copenhagen.
Coverage timeline — 1 article
MarketWatch
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
2026-06-08 08:44 UTC